nevirapine has been researched along with Central Nervous System Toxoplasmosis in 1 studies
Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saka, B | 1 |
| Barro-Traoré, F | 1 |
| Atadokpédé, FA | 1 |
| Kobangue, L | 1 |
| Niamba, PA | 1 |
| Adégbidi, H | 1 |
| Yedomon, HG | 1 |
| Traoré, A | 1 |
| Pitché, VP | 1 |
1 other study available for nevirapine and Central Nervous System Toxoplasmosis
| Article | Year |
|---|---|
Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa: a multicentric study in four countries.
Topics: Adolescent; Adult; Africa South of the Sahara; Aged; Aged, 80 and over; AIDS-Related Opportunistic I | 2013 |